SCHEMBL23748692

SCHEMBL23748692

CC/C=C\CCCCOc1cccc(C(=O)OC)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.44
HSP90AA1 P07900 2/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42
CYP2C19 P33261 1/20 0.42
LMNA P02545 3/20 0.42
CYP3A4 P08684 2/20 0.42
MEN1 O00255 1/20 0.42
NR1I2 O75469 1/20 0.42
CHRM2 P08172 1/20 0.42
ADRA2A P08913 1/20 0.42
OPRK1 P41145 1/20 0.42
HTR2B P41595 1/20 0.42
SLC6A3 Q01959 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28614075 1.00 MAPT (0.44) MAPTHSP90AA1HTTNPSR1ALDH1A1
SCHEMBL23748655 0.92 MAPT (0.43) MAPTHSP90AA1HTTNPSR1ALDH1A1
SCHEMBL23748649 0.87 KMT2A (0.44) MAPTALDH1A1LMNACYP3A4MEN1
SCHEMBL28612051 0.87 KMT2A (0.44) MAPTALDH1A1LMNACYP3A4MEN1
SCHEMBL19709550 0.86 MAPT (0.47) MAPTHSP90AA1HTTNPSR1ALDH1A1
SCHEMBL23748630 0.81 BID (0.43) MAPTHTTALDH1A1SMN1; SMN2LMNA
SCHEMBL28623010 0.81 BID (0.43) MAPTHTTALDH1A1SMN1; SMN2LMNA
SCHEMBL28620825 0.79 ALDH1A1 (0.44) MAPTNPSR1ALDH1A1CYP2C9LMNA
SCHEMBL25244052 0.79 MAPT (0.48) MAPTHSP90AA1HTTNPSR1ALDH1A1
SCHEMBL23748684 0.79 ALDH1A1 (0.44) MAPTNPSR1ALDH1A1CYP2C9LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-12-09 US disclosed
EP-3864001-A1 ROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-08-18 EP disclosed
CN-113166024-A Aromatic compounds and their medical use 巴斯夫股份公司 2021-07-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF GLS2, FFAR3, SLC10A1 MAPT 3583/4885HSP90AA1 3816/4885HTT 4209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.